Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8151
iShares US Utilities ETF
IDU
$1.35B
| $590K | ﹤0.01% |
6,130
-34,204
| -85% | -$3.45M |
|
8152
CALL
Pacira BioSciences
PCRX
$952M
| $590K | ﹤0.01% |
31,300
-74,200
| -70% | -$1.3M |
|
8153
StoneCo
STNE
$2.22B
| $590K | ﹤0.01% |
+73,979
| New | +$750K |
|
8154
CALL
Invesco S&P 500 Momentum ETF
SPMO
$22.1B
| $589K | ﹤0.01% |
6,200
-2,200
| -26% | -$209K |
|
8155
United States Brent Oil Fund
BNO
$647M
| $589K | ﹤0.01% |
19,668
-86,491
| -81% | -$2.55M |
|
8156
CALL
National Health Investors
NHI
$3.59B
| $589K | ﹤0.01% |
8,500
+3,400
| +67% | +$259K |
|
8157
CALL
QCR Holdings
QCRH
$1.71B
| $589K | ﹤0.01% |
7,300
+5,800
| +387% | +$488K |
|
8158
Chesapeake Utilities
CPK
$3.29B
| $588K | ﹤0.01% |
4,849
+4,240
| +696% | +$525K |
|
8159
First United
FUNC
$293M
| $588K | ﹤0.01% |
17,450
-8,292
| -32% | -$276K |
|
8160
Value Line
VALU
$336M
| $588K | ﹤0.01% |
11,136
+3,639
| +49% | +$185K |
|
8161
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$246M
| $587K | ﹤0.01% |
19,514
-12,013
| -38% | -$376K |
|
8162
CALL
10x Genomics
TXG
$7.3B
| $587K | ﹤0.01% |
40,900
-24,600
| -38% | -$388K |
|
8163
PUT
Blink Charging
BLNK
$81.3M
| $587K | ﹤0.01% |
422,500
+190,000
| +82% | +$336K |
|
|
GGRP
8164
Glimpse Group
GGRP
$20.2M
| $587K | ﹤0.01% |
237,709
+25,564
| +12% | +$28.3K |
|
8165
Innovator US Equity Buffer ETF October
BOCT
$289M
| $587K | ﹤0.01% |
+13,578
| New | +$586K |
|
8166
CALL
Ginkgo Bioworks
DNA
$440M
| $587K | ﹤0.01% |
59,762
-38
| -0.1% | -$326 |
|
8167
PUT
Kadant
KAI
$3.71B
| $586K | ﹤0.01% |
1,700
-3,100
| -65% | -$1.12M |
|
8168
PUT
Enpro
NPO
$7B
| $586K | ﹤0.01% |
+3,400
| New | +$575K |
|
8169
PUT
IDEX
IEX
$17.3B
| $586K | ﹤0.01% |
2,800
+1,100
| +65% | +$241K |
|
8170
TRI-Continental Corp
TY
$1.91B
| $586K | ﹤0.01% |
+18,492
| New | +$614K |
|
8171
Protolabs
PRLB
$2.04B
| $586K | ﹤0.01% |
14,989
-14,532
| -49% | -$522K |
|
8172
Atlanticus Holdings
ATLC
$1.5B
| $586K | ﹤0.01% |
10,501
-2,693
| -20% | -$128K |
|
8173
PUT
Jakks Pacific
JAKK
$288M
| $586K | ﹤0.01% |
20,800
-11,200
| -35% | -$307K |
|
8174
Precision BioSciences
DTIL
$224M
| $586K | ﹤0.01% |
153,675
+56,400
| +58% | +$412K |
|
8175
iShares Morningstar Small-Cap ETF
ISCB
$291M
| $585K | ﹤0.01% |
9,979
+6,549
| +191% | +$396K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.